(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Life Science Industry Banner - Advancing Healthcare Solutions
Mouse Scroll Icon
May 2021

Sparrow Pharmaceuticals, Inc Appoints Robert Jacks as Chief Executive Officer of the Company

Sparrow Pharmaceuticals, Inc announced the appointment of biopharmaceutical industry veteran Robert Jacks as Chief Executive Officer of the company.
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess – associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. It is privately held and based in Portland, Oregon.